chr9:133750356:A>G Detail (hg19) (ABL1)

Information

Genome

Assembly Position
hg19 chr9:133,750,356-133,750,356
hg38 chr9:130,874,969-130,874,969 View the variant detail on this assembly version.

HGVS

Type Transcript Protein
RefSeq NM_005157.5:c.1187A>G NP_005148.2:p.His396Arg
NM_007313.2:c.1244A>G NP_009297.2:p.His415Arg
Ensemble ENST00000318560.6:c.1187A>G ENST00000318560.6:p.His396Arg
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

ClinVar

Clinical Significance Pathogenic Likely pathogenic
Review star
Show details
Links
Type Database ID Link
Gene MIM 189980 OMIM
HGNC 76 HGNC
Ensembl ENSG00000097007 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC COSM12604 COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance Last evaluated Review status Condition Origin Links
Likely pathogenic 2015-07-14 no assertion criteria provided chronic myelogenous leukemia, BCR-ABL1 positive somatic Detail
Pathogenic 2019-04-30 no assertion criteria provided Lip and oral cavity carcinoma somatic Detail
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
chronic myeloid leukemia Imatinib D Predictive Supports Resistance Somatic 2 19075254 Detail
chronic myeloid leukemia Imatinib C Predictive Supports Resistance Somatic 15930265 Detail
chronic myeloid leukemia Bosutinib C Predictive Supports Resistance Somatic 1 22371878 Detail
chronic myeloid leukemia Bosutinib C Predictive Does Not Support Resistance Somatic 1 21865346 Detail
chronic myeloid leukemia Dasatinib B Predictive Does Not Support Resistance Somatic 3 19779040 Detail
chronic myeloid leukemia Axitinib D Predictive Supports Resistance Somatic 2 25686603 Detail
chronic myeloid leukemia Imatinib Mesylate D Predictive Supports Resistance Somatic 2 16772610 Detail
chronic myeloid leukemia Imatinib Mesylate C Predictive Supports Resistance Somatic 1 22371878 Detail
chronic myeloid leukemia Dasatinib C Predictive Does Not Support Resistance Somatic 3 16775234 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
A panel of 18 mutations representing 85% of known mutations seen in imatinib CML patents were used t... CIViC Evidence Detail
In two cell-based studies, a panel of either 18 or 16 mutations representing 85% of known mutations ... CIViC Evidence Detail
This was a retrospective study of dasatinib and/or nilotinib-resistant or -intolerant patients pretr... CIViC Evidence Detail
In this retrospective study, imatinib-resistant or -intolerant patients, with chronic phase CML and ... CIViC Evidence Detail
This is a retrospective study of imatinib-resistant (n = 805) or -intolerant (n = 238), chronic myel... CIViC Evidence Detail
In a proliferation assay measuring tritiated thymidine incorporation in the presence of axitinib, Ba... CIViC Evidence Detail
In an in vitro study, stochastic mutations were introduced into the ABL1 region of a stably expresse... CIViC Evidence Detail
In a study of 39 chronic phase CML patients with BCR-ABL variants, H396R was seen in a single imatin... CIViC Evidence Detail
Prior to dasatinib treatment, one imatinib-resistant patient with chronic myeloid leukemia in chroni... CIViC Evidence Detail
NM_005157.6(ABL1):c.1187A>G (p.His396Arg) AND Chronic myelogenous leukemia, BCR-ABL1 positive ClinVar Detail
NM_005157.6(ABL1):c.1187A>G (p.His396Arg) AND Lip and oral cavity carcinoma ClinVar Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs121913454 dbSNP
Genome
hg19
Position
chr9:133,750,356-133,750,356
Variant Type
snv
Reference Allele
A
Alternative Allele
G
Variant (CIViC) (CIViC Variant)
BCR-ABL H396R
Transcript 1 (CIViC Variant)
ENST00000318560.5
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/1030
Genome browser